US Stocks Focus

  • U.S. investment banks speak highly of Musk\’s visit to China: a watershed moment for Tesla

    Tesla CEO Elon Musk made a surprise visit to China on Sunday. A long-time Tesla bull analyst said the visit may be related to Tesla\’s launch of fully autonomous driving (FSD) software in China.

    US Stocks Focus 1 hour ago
  • Capital Economics warns: AI bubble will burst in 2026

    Capital Economics warns that AI-fueled stock market bubble could burst in 2026

    US Stocks Focus 1 hour ago
  • World Economic Forum President: The global debt problem is the most serious in more than 200 years

    World Economic Forum President Borge Brende warned in an interview at the World Economic Forum meeting in Saudi Arabia on Sunday that total global debt is approaching total global economic output.

    US Stocks Focus 1 hour ago
  • Buzzing stocks.Stocks that will see action today: April 29, 2024

    Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

    US Stocks Focus 1 hour ago
  • Buzzing stocks.Stocks that will see action today: April 29, 2024

    Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

    US Stocks Focus 1 hour ago
  • Buzzing stocks.Stocks that will see action today: April 29, 2024

    Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

    US Stocks Focus 1 hour ago
  • Buzzing stocks.Stocks that will see action today: April 29, 2024

    Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

    US Stocks Focus 1 hour ago
  • Buzzing stocks.Stocks that will see action today: April 29, 2024

    Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

    US Stocks Focus 1 hour ago
  • Buzzing stocks.Stocks that will see action today: April 29, 2024

    Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

    US Stocks Focus 1 hour ago